Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer

Not Applicable

Completed

• Conditions: Metastatic Breast Cancer
• Interventions: Behavioral: Nurse AMIE

• Registration Number: NCT03456973
• Lead Sponsor: Milton S. Hershey Medical Center

Brief Summary

The investigators propose to build and test a supportive care software platform called Nurse AMIE (Addressing Metastatic Individuals Everyday) to be provided to metastatic breast cancer patients on Android Tablets. This program will be tested in 50 metastatic breast cancer patients within the Penn State Cancer Institute's 28 county catchment area. The company with whom the investigator will partner to develop this application is already working with multiple investigators at the institution (Webster Group).

Detailed Description

Goals of the Nurse AMIE software program are to regularly assess psychosocial, functional, and symptom needs among metastatic breast cancer patients and to provide appropriate interventions via YouTube style videos, weekly Skype calls (face to face, tablet to tablet) with a patient navigator at Penn State, and appropriate referrals to phone or in person consultations as needed. The proposed Nurse AMIE software program will allow for the provision of resources (YouTube style videos, audio files, exercises) to intervene on many of the common symptoms and challenges experienced by metastatic patients. This is an identified need on the part of both metastatic patients and their medical care teams. Finally, it will also allow patient navigators to check in with patients, reviewing responses to surveys, discerning whether new or different interventions are needed, and connecting women to palliative care and other services if additional care is warranted.

Study Timeline

• Study First Submitted: 2017-06-06
• Study Start: 2017-10-01
• Study First Submitted QC: 2018-03-05
• Study First Posted: 2018-03-07
• Primary Completion: 2018-04-18
• Study Completion: 2018-04-18
• Status Verified: 2019-05
• Last Update Submitted: 2019-05-01
• Last Update Posted: 2019-05-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 7

Inclusion Criteria

1. Women with metastatic breast cancer
2. ECOG performance score ≤3.
3. English Speaking
4. With sufficient vision/hearing or family support

Exclusion Criteria

1. Medical or psychiatric conditions (beyond breast cancer, its treatment, and its symptoms) that would impair our ability to test study hypotheses (e. g. psychotic disorders, dementia, inability to give informed consent or follow the instruction).
2. Patients who are receiving any other behavioral intervention

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Nurse AMIE	Nurse AMIE	-

Primary Outcome Measures

Name	Time	Method
Feasibility- the proportion of patients who interact at least one month with tablet.	3 months	The proportion of women who consent, take a tablet home, who actually interact with the tablet and participate at least one month of the program.

Secondary Outcome Measures

Name	Time	Method
Acceptability - the proportion of patients who agree to participate	3 months	The proportion of patients who agree to participate among those deemed eligible and cleared by oncologist.

Trial Locations

Locations (1)

Penn State Cancer Institute; 🇺🇸 Hershey, Pennsylvania, United States